Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Domino-Synthesized Dicoordinate Copper(I) Bis-imidazopyridine Complex Triggering Cuproptosis/Ferroptosis for Enhanced Cancer Immunotherapy.

Angewandte Chemie (International ed. in English)·2026
Same author

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same author

MEG-mod: A Multiview Enhanced Graph Neural Network for Knockdown Efficiency Prediction of Chemically Modified siRNA.

Journal of medicinal chemistry·2026
Same author

ULCYP: A Multitask Model for Predicting P450 Inducers Based on Positive-Unlabeled Learning.

Journal of chemical information and modeling·2026
Same author

CypGEM: A Geometry-Aware and Edge-Enhanced Graph Transformer Model for Predicting Sites of Metabolism Mediated by Cytochromes P450.

Journal of chemical information and modeling·2026
Same author

EviCYP: <i>In Silico</i> Prediction of Cytochrome P450 Substrates Based on Vector Quantization and Evidential Deep Learning.

Journal of chemical information and modeling·2026

Related Experiment Video

Updated: Jun 12, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

wSDTNBI: a novel network-based inference method for virtual screening.

Zengrui Wu1, Hui Ma1, Zehui Liu1

  • 1Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology 130 Meilong Road Shanghai 200237 China ytang234@ecust.edu.cn huangjin@ecust.edu.cn.

Chemical Science
|February 25, 2022
PubMed
Summary

We developed wSDTNBI, a novel network-based virtual screening method using weighted drug-target interaction networks. This approach identified new RORγt inverse agonists, including ursonic acid, with therapeutic potential for multiple sclerosis.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K

Related Experiment Videos

Last Updated: Jun 12, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.6K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Bioinformatics

Background:

  • Network-based virtual screening (VS) is emerging for drug discovery.
  • Existing methods often use unweighted drug-target interaction (DTI) networks.

Purpose of the Study:

  • To introduce wSDTNBI, a novel network-based inference method for VS.
  • To utilize weighted DTI networks correlated with binding affinities for improved predictions.

Main Methods:

  • Developed wSDTNBI, employing a two-pronged approach with weighted DTI and drug-substructure association networks.
  • Applied wSDTNBI for network-based VS targeting retinoid-related orphan receptor γt (RORγt).
  • Experimentally validated predicted compounds through in vitro and in vivo studies.

Main Results:

  • Identified seven novel RORγt inverse agonists from 72 tested compounds.
  • Ursonic acid and oleanonic acid showed potent inhibition (IC50: 10 nM and 0.28 μM, respectively).
  • Confirmed direct interaction of ursonic acid with RORγt via X-ray crystallography; demonstrated therapeutic effects in multiple sclerosis models.

Conclusions:

  • wSDTNBI is a powerful tool for network-based VS in drug discovery.
  • Identified promising drug candidates for RORγt-related diseases.
  • Demonstrated the therapeutic potential of ursonic acid and oleanonic acid for multiple sclerosis.